Vitiligo: all 306 studies

Page 2 of 4. Open to participants first (69), then studies with results posted, then the rest; newest registration first within each.

• Comparative Study of Topical Pentoxifylline Versus Topical 5-Fluorouracil Combined With Microneedling and NB-UVB for Stable VitiligoCompletedNCT07775105Not applicable
• Autologous Nanofat Injection for Treatment of Stable VitiligoCompletedNCT07763262Not applicable
• Comparison of Gingival Depigmentation Using Microneedling and Microneedling With Glutathione Gel - A Split Mouth Clinical TrialCompletedNCT07748507Not applicable
• Topical Ruxolitinib Evaluation in Immune-related Vitiligo-like DepigmentationActive, not recruitingNCT07725432Phase 2
• Possible Augmentation Of NB-UVB Induced Pigmentation In NSV By Carboxy.Active, not recruitingNCT07563049Phase 4
• Tyrosine Vs Tacrolimus With NB-UVB in VitiligoCompletedNCT07532330Not applicable
• Nano Silver Effect in Rapid Wound HealingCompletedNCT07521176Not applicable
• Comparative Effectiveness of Ruxolitinib Monotherapy Versus Its Combination With Tacrolimus and Corticosteroids in the Management of Vitiligo: A Randomized Controlled TrialCompletedNCT07368673Phase 4
• Oral Mini Pulse Dexamethasone in Pediatric VitiligoCompletedNCT07353801Phase 4
• The Value of Methotrexate in NCES for Stable VitiligoCompletedNCT07352293Phase 4
• TRPM2 Gene Polymorphism, NLRP3 Inflammasome Expression in Vitiligo PatientsActive, not recruitingNCT07232238
• Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental VitiligoCompletedNCT07181187Phase 2
• A Comparative Study on the Efficacy of Blue Light Emitting Diodes Therapy Versus Targeted Narrow Band UVB in Stable Non-segmental Vitiligo Patients.CompletedNCT07174024Phase 4
• Effectiveness of Omega-3 Poly Unsaturated Fatty Acids on The Treatment of Gingival HyperpigmentationActive, not recruitingNCT07067515Phase 1/2
• The Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia.CompletedNCT07046039
• Efficacy of Oral Tofacitinib in Combination of Narrow Band UVB in Treatment of VitiligoActive, not recruitingNCT07044141Phase 1
• A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental VitiligoActive, not recruitingNCT06905873Phase 1
• Use of Allogeneic Extracellular Secretomes (EV)Derived From Umbilical Cord Mesenchymal Stromal Cells: a Phase I Open-label Safety Trial.Active, not recruitingNCT06813027Phase 1
• A Trial of SHR0302Base in Patients With VitiligoActive, not recruitingNCT06790862Phase 2
• Evaluation of Serological Markers of Vitiligo ActivityActive, not recruitingNCT06731283
• Transplantation of Autologous Non-Cultured Extracted Hair Follicle Outer Root Sheath Cell Suspension and Mini Punch Graft for Stable Non-Segmental Vitiligo LesionsCompletedNCT06619184Not applicable
• A Study of DR-01 in Subjects With Alopecia Areata and VitiligoActive, not recruitingNCT06602232Phase 1
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.TerminatedNCT06493578Phase 2
• Efficacy & Tolerance of Cosmetic Product RV5098A on Face Pigmentation Maintenance in Adult Vitiligo Patients.TerminatedNCT06446063
• Assessment of Hypoxia Inducible Factor and Autophagy Related Genes in Patients With Non-Segmental VitiligoStatus unknownNCT06410898Not applicable
• Effect of Platelet Rich Plasma on Outcome of Narrow Band UVB in Treatment of Vitiligo; Clinical and Histopathological StudyActive, not recruitingNCT06370650Not applicable
• Vitiligo Treatment by Targeting TYK2 Mediated ResponsesActive, not recruitingNCT06327321Phase 2
• Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEasesCompletedNCT06324695Not applicable
• 5-fluorouracil for Treatment of Stable VitiligoCompletedNCT06209138Not applicable
• A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental VitiligoActive, not recruitingNCT06163326Phase 3
• A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With VitiligoActive, not recruitingNCT06118411Phase 3
• A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With VitiligoActive, not recruitingNCT06109649Phase 3
• Translational Assessment of Vitiligo According to Body LocationsCompletedNCT06068218Not applicable
• Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on ChildrenCompletedNCT06035614Not applicable
• Vitiligo and Psychodrama TherapyCompletedNCT05991596Not applicable
• Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ CellsCompletedNCT05971381Not applicable
• Correlation of Glucose and Lipid Metabolism Levels With VitiligoCompletedNCT05968235
• Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive VitiligoStatus unknownNCT05917561Phase 2
• Promoting Repigmentation After Epidermal Cell Suspension Grafting and preVENTing the Loss of Melanocytes Using Topical Ruxolitinib for Vitiligo in Resistant AreasCompletedNCT05872477Phase 2
• Improved Phototherapy in Patients With VitiligoStatus unknownNCT05836441Not applicable
• T Central Memory Cells in Early Localized Non-Segmental VitiligoCompletedNCT05706636Not applicable
• Secukinumab in Active Non-segmental VitiligoCompletedNCT05676333Phase 4
• Evaluating the Efficacy and Safety of Metformin in VitiligoWithdrawnNCT05607316Phase 2
• Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for the Treatment of VitiligoCompletedNCT05577637Phase 1
• How Does Skin Tone Affect Quantitative Photoacoustic ImagingStatus unknownNCT05554523
• Assessment of Serum Leptin in Vitiligo PatientsStatus unknownNCT05549869Not applicable
• In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory DiseasesCompletedNCT05544448Not applicable
• Assessment of Circulating Fubctional Mitochondrias in Vitiligo PatientsActive, not recruitingNCT05525741Not applicable
• Comparative Study Between Topical 5-fluorouracil and Latanoprost in Vitiligo.CompletedNCT05513924Phase 2/3
• Efficacy of PRP With Er-YAG Laser Versus With Microneedling in Localized Stable VitiligoStatus unknownNCT05511493Not applicable
• Tissue-resident Memory T Cells Expression Among the Repigmentation Patterns Induced by NB-UVB Phototherapy in VitiligoCompletedNCT05506995
• Autologous Cellular Graft in Surgical Treatment of VitiligoSuspendedNCT05503368Not applicable
• Evaluation of Efficacy of Microneedling and Topical Methotrexate Versus Microneedling and Topical 5-flourouracil in Treatment of Vitillgo PatientsCompletedNCT05467839Not applicable
• Sensory Symptoms in Active VitiligoStatus unknownNCT05390164
• Synergistic Effect of Vitamin D Supplementation in Patients With Vitiligo and Vitamin D DeficiencyCompletedNCT05364567Not applicable
• Daily Topical Rapamycin for VitiligoActive, not recruitingNCT05342519Phase 2
• Ocular Changes in Vitiligo Patients on TherapyStatus unknownNCT05335746
• Effect of NB-UVB on the Tissue Level of IL 15 and IL-15Rα in Active Non Segmental Vitiligo Cases.CompletedNCT05316987Not applicable
• Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in VitiligoCompletedNCT05298033Phase 2
• Role of Tofacitinib in Vitiligo PatientsStatus unknownNCT05293119Early Phase 1
• Role of NGAL in VitiligoStatus unknownNCT05290077Not applicable
• E-cadherin and Integrin Alpha v Beta 1 in VitiligoStatus unknownNCT05287776Not applicable
• Effect of Combination Non Steroidal Antiinflammatory Drugs and Narrowband UVB Treatment in Non-PhotoadaptersTerminatedNCT05256147Not applicable
• Comparing the Efficacy of Visible Light-Ultraviolet A1 Light Versus Narrowband-Ultraviolet B on Generalized VitiligoTerminatedNCT05238077Not applicable
• Enhanced Transcutaneous Delivery of Betamethasone for the Treatment of VitiligoStatus unknownNCT05233735Not applicable
• Resident Memory T Cells in VitiligoStatus unknownNCT05223738
• A Study to Assess the Changes in Pigmentation and Safety of Afamelanotide in Patients With Vitiligo on the FaceStatus unknownNCT05210582Phase 2
• Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental VitiligoStatus unknownNCT05121532Not applicable
• The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech RepublicCompletedNCT05098600
• A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for VitiligoCompletedNCT05053022Not applicable
• Effect of Early Systemic Stabilization Therapy on Recent Onset VitiligoCompletedNCT05037981
• Fractional CO2 Laser-assisted Cutaneous Delivery of Methotrexate Versus 5-fluorouracil in Stable Non-segmental VitiligoStatus unknownNCT05008887Phase 4
• Pilot Study Assessing the Effect of Tildrakizumab in VitiligoCompletedNCT04971200Early Phase 1
• The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active VitiligoCompletedNCT04942860Phase 3
• Search for New Predictive Markers of the Immune Response in Vitiligo and MelanomaCompletedNCT04920162Not applicable
• Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for VitiligoCompletedNCT04872257Not applicable
• Hair Transplantation for Treatment of VitiligoWithdrawnNCT04858152Not applicable
• ERASE VITILIGO Early Repigmentation Approach for Stopping the Evolution of VITILIGO Prospective Multicentric Interventional Study With Blinded EvaluationCompletedNCT04843059Not applicable
• Evaluation of Effect and Tolerance of the Association of Baricitinib and Phototherapy Versus Phototherapy in Adults With Progressive VitiligoCompletedNCT04822584Phase 2
• Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory EvaluationActive, not recruitingNCT04811326Phase 4
• Catecholamines Level in Vitiligo Patients Before and After Excimer LightStatus unknownNCT04803461
• Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-upStatus unknownNCT04789993
• Diphenylcyclopropenone (DPCP) as a Depigmenting Therapy in Extensive VitiligoCompletedNCT04775979Phase 4
• Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With VitiligoTerminatedNCT04774809Phase 2/3
• Comparison Between Systemic Steroids, Topical Steroids, or Calcineurin Inhibitors With Mini Punch Grafting in Treatment of Stable Non-segmental VitiligoStatus unknownNCT04765826Not applicable
• Effect of Microneedling, Bimatoprost and Excimer in Vitiligo TreatmentCompletedNCT04738149Early Phase 1
• Defining the Role of the Skin Microbiome in Immune-related Adverse EventsTerminatedNCT04734704Not applicable
• Effect Of Topical Prostaglandin F2α Analogs,Fractional CO2 Laser, Excimer Laser Or Their Combination In Treatment Of VitiligoStatus unknownNCT04577027Phase 4
• Phototherapy Combination With Topicals in VitiligoStatus unknownNCT04440371Not applicable
• Evaluation of Human Melanocytes After the Use of PRP Versus Fractional CO2 Laser in VitiligoStatus unknownNCT04320160Not applicable
• Efficacy of Red Light in the Treatment of Pigmentary DisordersStatus unknownNCT04308421Not applicable
• Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo LesionsTerminatedNCT04271501Not applicable
• Combined Effect of Acitretin and Narrow Band Ultraviolet B on Vitiligo RepigmentationStatus unknownNCT04245319Not applicable
• The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataCompletedNCT04239521
• Combination of Methotrexate and Phototherapy Versus Phototherapy in Adults With Progressive VitiligoCompletedNCT04237103Phase 2
• Evaluation of the Efficacy and the Cutaneous Acceptability of a Dermocosmetic Product in the Repigmentation of VitiligoStatus unknownNCT04171427Not applicable
• Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With VitiligoCompletedNCT04103060Phase 2
• Prevalence of Psoriasis and Vitiligo in Assiut Governorate, EgyptStatus unknownNCT04039451
• Contribution of Skin Color in Stabilization of Active Cases of Vitiligo by Narrow Band UVBStatus unknownNCT04030988Phase 1
• Effects of Combination Therapy With Camouflage in the Repigmentation of VitiligoCompletedNCT03973073Phase 1

← Vitiligo overview